Sartans API Market Key Companies Profile and SWOT Analysis by 2031
Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031Coverage: Sartans API Market covers analysis By Product (Valsartan, Irbesartan, Telmisartan, Losartan, Others); Applications (Anti-Hypertension, Anti-Viral, Others),Impact of covid-19 pandemic., and Geography (North America, Europe, Asia Pacific, and South and Central America)
- Report Date : Aug 2025
- Report Code : TIPRE00015289
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 150
MARKET INTRODUCTION
Sartans acts as an angiotensin receptor antagonists that helps in blocking the action of angiotensin that allows the dilation of blood vessels. Angiotensin are the chemicals in the human body that affect the heart by narrowing down the blood vessels that do not allow the required space to the blood to move, resulting in increasing blood pressure, also called as hypertension, and cardiovascular risks. Leading brands in the Sartans API market include Benicar (olmesartan medoxomil), Diovan (valsartan), Micardis (telmisartan), Cozaar (Osartan), EdSartans APIi (Azilsartan), Atacand (candesartan), Teveten (eprosartan), and Avapro (irbesartan). Sartans APIs help in the treatment of conditions, such as, high blood pressure, cardiac failure, chronic kidney diseases, and kidney failure in diabetes.
MARKET DYNAMICS
Market for Sartans API market is driving due to factors such as increasing prevalence of hypertension, cardiovascular disorders and kidney failure in diabetics, increasing geriatric population and commercial availability of Sartans as generic medicines. However, stringent government regulations associated with manufacturing of APIs and strong competition in generic market is expected to hamper the market growth.
MARKET SCOPE
The Sartans API market analysis to 2031 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Sartans API market with detailed market segmentation by product and application. The Sartans API market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Sartans API market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Sartans API market is segmented on the basis of product and application. Based on product, the market is segmented as Valsartan, Irbesartan, Telmisartan, Losartan, others. Based on application, market is segmented as Anti-Hypertension, Anti-Viral, Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Sartans API market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Sartans API market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Sartans API market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Sartans API market in these regions.
MARKET PLAYERS
The report covers key developments in the Sartans API market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Sartans API market are anticipated to have lucrative growth opportunities in the future with the rising demand for Sartans API in the global market. Below mentioned is the list of few companies engaged in the Sartans API market.
The report also includes the profiles of key players in Sartans API market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer
- Novartis
- Merck
- AstraZeneca
- Eli Lilly
- Sanofi
- Bristol-Myers Squibb
- Bayer
- Huahai Pharmaceutical
- Teva Pharmaceutical
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Sartans API Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ XX million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2025 - 2031) | XX% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
1. Pfizer
2. Novartis
3. Merck
4. AstraZeneca
5. Eli Lilly
6. Sanofi
7. Bristol-Myers Squibb
8. Bayer
9. Huahai Pharmaceutical
10. Teva Pharmaceutical
Get Free Sample For